Modlin NL

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

15 papers · ORCID

ArticlePsilocybin

Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.

Rucker JJ, Mantingh T, Kerr-Gaffney J +26

Europe PMC2026
ArticlePsilocybin

Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder.

Dougherty RF, Modlin NL, McGowan NM +11

Europe PMC2026
ArticleMDMA

Psychodynamic Perspectives on Psychedelic States and Treatment Contexts: A Conceptual and Clinical Introduction.

Modlin NL, Elek Z, Maggio C +5

Europe PMC2026
ArticlePsilocybin

Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experience.

Kerr-Gaffney J, Myrtle S, Askari F +4

Europe PMC2026
ArticlePsilocybin

Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.

Modlin NL, Williamson V, Goodwin GM +10

Europe PMC2025
ArticlePsilocybin

Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.

McGowan NM, Rucker JJ, Yehuda R +6

Europe PMC2026
ArticlePsilocybin

Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.

Modlin NL, Jessica L MK, Sarang M +6

Europe PMC2025
ArticlePsilocybin

Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.

Modlin NL, Williamson V, Maggio C +4

Europe PMC2025
ArticlePsilocybin

Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa.

Peck SK, Brewerton TD, Fisher H +6

Europe PMC2025
ArticlePsilocybin

Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.

Modlin NL, McPhee T, Zazon N +6

Europe PMC2025
ArticlePsilocybin

Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.

Kirlić N, Lennard-Jones M, Atli M +6

Europe PMC2025
ArticlePsychedelics

A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials.

Kishon R, Modlin NL, Cycowicz YM +5

Europe PMC2024
ArticlePsilocybin

Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.

Modlin NL, Creed M, Sarang M +3

Europe PMC2024
ArticlePsilocybin

Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.

Modlin NL, Miller TM, Rucker JJ +4

Europe PMC2023
ArticlePsilocybin

Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.

Rucker J, Jafari H, Mantingh T +7

Europe PMC2021